1. Chemical genetics strategy to profile kinase target engagement reveals role of FES in neutrophil phagocytosis
- Author
-
Tim van den Hooven, Joost A. P. M. Wijnakker, Tjeerd Barf, Herman S. Overkleeft, Hans den Dulk, Rob Ruijtenbeek, Tom van der Wel, Eelke B. Lenselink, Allard Kaptein, Gerard J. P. van Westen, Bogdan I. Florea, Nienke M. Prins, Mario van der Stelt, and Riet Hilhorst
- Subjects
0301 basic medicine ,Neutrophils ,Science ,Cellular differentiation ,General Physics and Astronomy ,Kinases ,Article ,Chemical genetics ,General Biochemistry, Genetics and Molecular Biology ,Cell Line ,03 medical and health sciences ,0302 clinical medicine ,Phagocytosis ,Fluorescence Resonance Energy Transfer ,Humans ,Syk Kinase ,CRISPR ,lcsh:Science ,Sensors and probes ,Fluorescent Dyes ,Gene Editing ,Multidisciplinary ,Drug discovery ,Chemistry ,Kinase ,Cas9 ,Macrophages ,Cell Differentiation ,General Chemistry ,Protein-Tyrosine Kinases ,Cell biology ,030104 developmental biology ,Proto-Oncogene Proteins c-fes ,030220 oncology & carcinogenesis ,Mutation ,lcsh:Q ,ATP-Binding Cassette Transporters ,CRISPR-Cas Systems ,Signal transduction ,Chemical tools ,Tyrosine kinase ,Signal Transduction - Abstract
Chemical tools to monitor drug-target engagement of endogenously expressed protein kinases are highly desirable for preclinical target validation in drug discovery. Here, we describe a chemical genetics strategy to selectively study target engagement of endogenous kinases. By substituting a serine residue into cysteine at the DFG-1 position in the ATP-binding pocket, we sensitize the non-receptor tyrosine kinase FES towards covalent labeling by a complementary fluorescent chemical probe. This mutation is introduced in the endogenous FES gene of HL-60 cells using CRISPR/Cas9 gene editing. Leveraging the temporal and acute control offered by our strategy, we show that FES activity is dispensable for differentiation of HL-60 cells towards macrophages. Instead, FES plays a key role in neutrophil phagocytosis via SYK kinase activation. This chemical genetics strategy holds promise as a target validation method for kinases., Chemical tools to monitor drug-target engagement of endogenous enzymes are essential for preclinical target validation. Here, the authors present a chemical genetics strategy to study target engagement of endogenous kinases, achieving specific labeling and inactivation of FES kinase to provide insights into FES’ role in neutrophil phagocytosis.
- Published
- 2020